Bettina Gerner

Physiologically Based Pharmacokinetic Modelling of Cabozantinib to Simulate Enterohepatic Recirculation, Drug–Drug Interaction with Rifampin and Liver Impairment

Bettina Gerner, O. Scherf-Clavel, Oliver Scherf-Clavel, 2021, Pharmaceutics.

A Physiologically-Based Pharmacokinetic Model of Ruxolitinib and Posaconazole to Predict CYP3A4-Mediated Drug–Drug Interaction Frequently Observed in Graft versus Host Disease Patients

Bettina Gerner, O. Scherf-Clavel, H. Klinker, 2022, Pharmaceutics.